News

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
As Wall Street puts April's tariff shakeout in the rearview mirror and indexes set record highs, investors remain wary of U.S ...
European stocks rose sharply Friday after U.S. Commerce Secretary Howard Lutnick said the U.S. and China had agreed to restore their trade truce and that more deals were imminent. Also lifting the ...
Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...
Marissa Mayer is now chief executive of Sunshine AI, a technology startup she founded that automates everyday tasks. The coffee chain also added Dambisa Moyo to the board.
European Union leaders are meeting in Brussels to address key global and regional issues. They will discuss Thursday tougher ...
Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other ...
Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...
Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...